<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Multiple Myeloma News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/multiple_myeloma/</link>
		<description>Read the latest news and information about multiple myeloma and related conditions, including potential symptoms, causes and treatments of the disease.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 22:39:52 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 22:39:52 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Multiple Myeloma News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/multiple_myeloma/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/multiple_myeloma" /><feedburner:info uri="sciencedaily/health_medicine/multiple_myeloma" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/multiple_myeloma</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>Researchers discover underlying cause of myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/_mCGxp1i_uQ/160211090240.htm</link>
			<description>Researchers have identified what causes a third of all myelomas, a type of cancer affecting plasma cells. The findings could fundamentally change the way this cancer and others are treated.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/_mCGxp1i_uQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 11 Feb 2016 09:02:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160211090240.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160211090240.htm</feedburner:origLink></item>
		<item>
			<title>Cancer treatment: Therapeutic approach gives hope for the treatment of multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/0BO5eHMkRac/160205100605.htm</link>
			<description>A new therapeutic approach gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy. The study resulted in a total cure rate of 41 percent, a record level using this strategy. Moreover, patients in complete remission six months after the allograft had a relapse-free survival rate of 60 percent.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/0BO5eHMkRac" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 05 Feb 2016 10:06:05 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160205100605.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160205100605.htm</feedburner:origLink></item>
		<item>
			<title>Pomalidomide in multiple myeloma: No hints of added benefit</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/hmDsUZlG6GI/160112102029.htm</link>
			<description>Pomalidomide has been approved since 2013 for the treatment of multiple myeloma that has returned and is difficult to treat. Researchers recently examined in a dossier assessment whether this drug offers an added benefit over the appropriate comparator therapy. No such added benefit could be derived, however, because the dossier contained no suitable data.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/hmDsUZlG6GI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 12 Jan 2016 10:20:29 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160112102029.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160112102029.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma study pivotal for FDA approval of daratumumab</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/4jDg8obpRqQ/160106215523.htm</link>
			<description>Multiple myeloma testing of daratumumab (trade name Darzalex) have received accelerated approval from the US FDA in November 2015.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/4jDg8obpRqQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 06 Jan 2016 21:55:23 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160106215523.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160106215523.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma drug could revolutionize treatment for sickle cell disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/Gh5u04NtThc/151217151653.htm</link>
			<description>An established drug for recurrent multiple myeloma might effectively be repurposed to improve the survival and day-to-day lives of patients with devastating sickle cell disease, according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/Gh5u04NtThc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 Dec 2015 15:16:53 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151217151653.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151217151653.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma patient study shows promise for natural killer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/EBjMB72hkBI/151207214745.htm</link>
			<description>A first-in-human Phase I study of multiple myeloma patients combined expanded cord blood-derived natural killer cells with transplantation of a patient's own stem cells and high-dose chemotherapy with little or none of the side effects seen with current treatments.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/EBjMB72hkBI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 07 Dec 2015 21:47:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151207214745.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151207214745.htm</feedburner:origLink></item>
		<item>
			<title>Three studies point to effectiveness of new therapies for multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/oclCjBVXlhI/151207165330.htm</link>
			<description>New drug combinations can significantly extend the time in which multiple myeloma is kept in check in patients with relapsed or treatment-resistant forms of the disease, new research indicates.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/oclCjBVXlhI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 07 Dec 2015 16:53:30 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151207165330.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151207165330.htm</feedburner:origLink></item>
		<item>
			<title>New pathway underlying multiple myeloma relapse</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/ynmChPzIVUc/151206213538.htm</link>
			<description>One of the biggest questions about the treatment of multiple myeloma, a form of blood cancer, is why nearly all patients treated with current therapies eventually suffer relapse. A new study may have solved this mystery by identifying how cancer cells escape treatment, leading to recurrence.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/ynmChPzIVUc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 06 Dec 2015 21:35:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151206213538.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151206213538.htm</feedburner:origLink></item>
		<item>
			<title>New vaccine strategy better protects high-risk cancer patients from flu</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/jrDwogn9b_U/151206213010.htm</link>
			<description>Researchers have developed a vaccine strategy that reduces the risk of flu infections in cancer patients at highest risk for influenza.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/jrDwogn9b_U" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 06 Dec 2015 21:30:10 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151206213010.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151206213010.htm</feedburner:origLink></item>
		<item>
			<title>How to wake a sleeping cancer cell, and why you might want to</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/it-AUOuAAWc/151203081222.htm</link>
			<description>Cancer cells that lie 'snoozing' in the skeleton can be awakened by changes in the bone that surrounds them, scientists have shown. In a world first, researchers have used state-of-the-art microscopy techniques to watch cancer cells sleep within living bone over a period of months. They show that cancer cells can be 'woken up' when bone tissue is broken down around them, suggesting new possibilities for treating metastatic cancer in bone.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/it-AUOuAAWc" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151203081222.jpg" height="192" width="300" />
			<pubDate>Thu, 03 Dec 2015 08:12:22 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151203081222.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151203081222.htm</feedburner:origLink></item>
		<item>
			<title>Personalized drug screening on horizon for multiple myeloma patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/DeJ6WS-12Bk/151120104008.htm</link>
			<description>A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer. The process also may aid patients with leukemia or lymphoma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/DeJ6WS-12Bk" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/11/151120104008.jpg" height="449" width="300" />
			<pubDate>Fri, 20 Nov 2015 10:40:08 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151120104008.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151120104008.htm</feedburner:origLink></item>
		<item>
			<title>First-in-class investigational therapeutic shows early promise for lymphoma patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/YbiGMJrI9kE/151111055315.htm</link>
			<description>Results from a phase I clinical trial showed that the first-in-class, investigational, anticancer therapeutic pevonedistat was safe, tolerable, and had some anticancer activity in heavily pretreated patients with relapsed/refractory lymphoma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/YbiGMJrI9kE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 11 Nov 2015 05:53:15 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151111055315.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151111055315.htm</feedburner:origLink></item>
		<item>
			<title>Scientists find evidence of how incurable cancer develops</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/HV5SuyrMXjo/151016115440.htm</link>
			<description>Researchers have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder. The findings could lead to more effective treatments and ways to identify those most at risk of developing the cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/HV5SuyrMXjo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 16 Oct 2015 11:54:40 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151016115440.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151016115440.htm</feedburner:origLink></item>
		<item>
			<title>Study lays groundwork for blood test to aid in the detection and monitoring of myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/cPc5t5o849Y/150930073114.htm</link>
			<description>Only 5 percent of myeloma cases are stage I when diagnosed. One reason may be the lack of good routine screening tests to identify patients who will progress to myeloma. A new study has found that abnormal levels of microRNAs (miRNAs) detected in the bone marrow of multiple myeloma patients may also be detectable in peripheral blood, and their measurement may be a way to both mark myeloma onset and track its progression from earlier asymptomatic stages.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/cPc5t5o849Y" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 30 Sep 2015 07:31:14 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150930073114.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150930073114.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma patients more vulnerable to 'financial toxicity' due to expensive, longer courses of treatments</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/HDaXzl6KTHI/150916185109.htm</link>
			<description>Even patients with health insurance who have multiple myeloma may be vulnerable to âfinancial toxicityâ because of the higher use of novel therapeutics and extended duration of myeloma treatment, researchers report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/HDaXzl6KTHI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 16 Sep 2015 18:51:09 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150916185109.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150916185109.htm</feedburner:origLink></item>
		<item>
			<title>Sustained remission of multiple myeloma after personalized cellular therapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/6g7YptYFW5A/150909213412.htm</link>
			<description>A multiple myeloma patient whose cancer had stopped responding after nine different treatment regimens experienced a complete remission after receiving an investigational personalized cellular therapy known as CTL019. The investigational treatment was combined with chemotherapy and an autologous stem cell transplant -- a new strategy designed to target and kill the cells that give rise to myeloma cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/6g7YptYFW5A" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 09 Sep 2015 21:34:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150909213412.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150909213412.htm</feedburner:origLink></item>
		<item>
			<title>Study finds increased risk of MGUS in Vietnam Vets exposed to Agent Orange</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/jqrqAVozSWQ/150903131414.htm</link>
			<description>A study that used stored blood samples from US Air Force personnel who conducted aerial herbicide spray missions of Agent Orange during the Vietnam war found a more than two-fold increased risk of the precursor to multiple myeloma known as monoclonal gammopathy of undetermined significance (MGUS), according to an article.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/jqrqAVozSWQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Sep 2015 13:14:14 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/09/150903131414.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/09/150903131414.htm</feedburner:origLink></item>
		<item>
			<title>Immunotherapy agent benefits patients with drug-resistant multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/R6CPsnxAXqo/150826204222.htm</link>
			<description>In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/R6CPsnxAXqo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 26 Aug 2015 20:42:22 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150826204222.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150826204222.htm</feedburner:origLink></item>
		<item>
			<title>Scientists, NASA astronauts developing near real-time osteoporosis, bone cancer test</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/I32KBcJeY10/150817220237.htm</link>
			<description>A test in development offers the possibility of near real time monitoring of bone diseases, such as osteoporosis and multiple myeloma. The test, which measures changes in calcium isotope ratios, uses techniques from geochemistry, and has been validated on blood samples from NASA space shuttle astronauts.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/I32KBcJeY10" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 17 Aug 2015 22:02:37 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150817220237.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150817220237.htm</feedburner:origLink></item>
		<item>
			<title>Genetic test could improve blood cancer treatment</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/trHbgtEJMhE/150817181304.htm</link>
			<description>Testing for genetic risk factors could improve treatment for myeloma -- a cancer of the blood and bone marrow -- by helping doctors identify patients at risk of developing more aggressive disease. New research found as few as nine genetic features would need to be tested to identify high-risk patients who might benefit from intensive treatment.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/trHbgtEJMhE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 17 Aug 2015 18:13:04 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/08/150817181304.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/08/150817181304.htm</feedburner:origLink></item>
		<item>
			<title>Poor survival in multiple myeloma patients linked to genetic variation</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/efG6SYsa_H0/150722082041.htm</link>
			<description>Multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with a genetic mapping technique, genome wide association studies (GWAS), and verified in patient populations from North America and Europe. This was the first study to survey the entire human genome for genetic variation influencing survival, and is a first step toward applying precision medicine to multiple myeloma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/efG6SYsa_H0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 22 Jul 2015 08:20:41 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150722082041.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150722082041.htm</feedburner:origLink></item>
		<item>
			<title>T-cell receptor therapy achieves encouraging clinical responses in multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/hnHHn9KvCBg/150720114749.htm</link>
			<description>Results from a clinical trial investigating a new T cell receptor therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response in 80 percent of multiple myeloma patients with advanced disease after undergoing autologous stem cell transplants.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/hnHHn9KvCBg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 20 Jul 2015 11:47:49 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150720114749.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150720114749.htm</feedburner:origLink></item>
		<item>
			<title>Leisure time sitting linked to higher risk of specific cancers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/e6CZUdyYX5I/150713131429.htm</link>
			<description>Spending more leisure time sitting was associated with a higher risk of total cancer risk in women, and specifically with multiple myeloma, breast, and ovarian cancers, according a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/e6CZUdyYX5I" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 13 Jul 2015 13:14:29 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150713131429.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150713131429.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma hides in bones like a wolf in sheep's clothing</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/wdTHBOzhkr4/150709141312.htm</link>
			<description>Multiple myeloma uses a trick akin to a wolf in sheepâs clothing to grow in and spread to new bone sites. By overexpressing Runx2, a gene that normally is a master regulator of bone formation, the cells of this largely incurable cancer produce proteins that mimic the normal bone-resident cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/wdTHBOzhkr4" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 09 Jul 2015 14:13:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/07/150709141312.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/07/150709141312.htm</feedburner:origLink></item>
		<item>
			<title>Navigating multiple myeloma with 'Google Maps' for the cancer genome</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/lYOhBvyTYrs/150608151942.htm</link>
			<description>A new approach for studying the cancer genome has been described by researchers who say that it will let scientists account for both the individual tiles and the whole mosaic. It enables researchers and clinicians to look at the small- and large-scale genetic changes that define individual cancers, they add.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/lYOhBvyTYrs" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/06/150608151942.jpg" height="199" width="300" />
			<pubDate>Mon, 08 Jun 2015 15:19:42 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/06/150608151942.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/06/150608151942.htm</feedburner:origLink></item>
		<item>
			<title>Nanotherapy effective in mice with multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/QFVyUVqZirU/150521091850.htm</link>
			<description>A nanoparticle-based therapy has been designed by researchers that is effective in treating mice with multiple myeloma, a cancer of immune cells in the bone marrow. Targeted specifically to the malignant cells, these nanoparticles protect their therapeutic cargo from degradation in the bloodstream and greatly enhance drug delivery into the cancer cells. These are longtime hurdles in the development of this class of potential cancer drugs.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/QFVyUVqZirU" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/05/150521091850.jpg" height="203" width="300" />
			<pubDate>Thu, 21 May 2015 09:18:50 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/05/150521091850.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/05/150521091850.htm</feedburner:origLink></item>
		<item>
			<title>Injected immune cells safe in multiple myeloma patients, pilot study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/nvF5pCwCOyI/150520140612.htm</link>
			<description>In a report on what is believed to be the first small clinical trial of its kind, researchers say they have safely used immune cells grown from patientsâ own bone marrow to treat multiple myeloma, a cancer of white blood cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/nvF5pCwCOyI" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 20 May 2015 14:06:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/05/150520140612.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/05/150520140612.htm</feedburner:origLink></item>
		<item>
			<title>New cancer treatment, prevention studies signal major advances for children, adults</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/Tn_Kb5gvdpA/150514095827.htm</link>
			<description>Results from four major studies have been announced by experts, showing that: use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/Tn_Kb5gvdpA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 14 May 2015 09:58:27 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/05/150514095827.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/05/150514095827.htm</feedburner:origLink></item>
		<item>
			<title>Shell-less chicken eggs for multiple myeloma research</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/SNBwQAratAc/150504082606.htm</link>
			<description>Scientists have grown miniature tumors on eggshell membranes. The EU project succeeded in developing an urgently needed drug screening system for bone marrow cancer, the scientists say. Multiple myeloma is an incurable cancer of the bone marrow.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/SNBwQAratAc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 04 May 2015 08:26:06 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/05/150504082606.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/05/150504082606.htm</feedburner:origLink></item>
		<item>
			<title>Stem cell transplantation for multiple myeloma: New data did not change conclusion</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/YTMvOAVaQNo/150429101110.htm</link>
			<description>After an update search, reviewers were able to include further studies in the assessment. The evidence base remained insufficient, however, and results of large studies remain unpublished.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/YTMvOAVaQNo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 29 Apr 2015 10:11:10 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/04/150429101110.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/04/150429101110.htm</feedburner:origLink></item>
		<item>
			<title>Effect of follow-up of MGUS on survival in patients with multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/o2RLdjNISIs/150305125525.htm</link>
			<description>Patients with multiple myeloma appear to have better survival if they are found to have monoclonal gammopathy of undetermined significance first, the state that precedes MM and which is typically diagnosed as part of a medical workup for another reason, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/o2RLdjNISIs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 05 Mar 2015 12:55:25 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/03/150305125525.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/03/150305125525.htm</feedburner:origLink></item>
		<item>
			<title>How to attack and paralyze myeloma cells: Comprehensive review on multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/FbzfyXgJSRk/150120085821.htm</link>
			<description>Multiple myeloma is a malignant disease characterized by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or urine. Increased understanding of the microenvironmental interactions between malignant plasma cells and the bone marrow niche, and their role in disease progression and acquisition of therapy resistance, has helped the development of novel therapeutic drugs for use in combination with cytostatic therapy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/FbzfyXgJSRk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 20 Jan 2015 08:58:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/01/150120085821.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/01/150120085821.htm</feedburner:origLink></item>
		<item>
			<title>Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/sBE1gCA2jZg/141207222858.htm</link>
			<description>Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers have found. The study suggests that attacking those subsets with targeted drugs may degrade the disease's ability to spread throughout the bone marrow of affected patients, the authors say.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/sBE1gCA2jZg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 07 Dec 2014 22:28:58 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/12/141207222858.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/12/141207222858.htm</feedburner:origLink></item>
		<item>
			<title>Circulating RNA may provide prognostic tool for multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/MreCoQZXnKg/141207091652.htm</link>
			<description>The 'molecular mail' sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/MreCoQZXnKg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 07 Dec 2014 09:16:52 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/12/141207091652.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/12/141207091652.htm</feedburner:origLink></item>
		<item>
			<title>Unprecedented benefit seen in worldwide test of a three-drug treatment for multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/0WdIt01ESbA/141207091428.htm</link>
			<description>In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/0WdIt01ESbA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 07 Dec 2014 09:14:28 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/12/141207091428.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/12/141207091428.htm</feedburner:origLink></item>
		<item>
			<title>Investigational oral drug combo shows promise for newly diagnosed multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/7xoF8ecMQjw/141117164409.htm</link>
			<description>The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study. "The all-oral combination of weekly ixazomib plus lenalidomide and dexamethasone was generally well tolerated and appeared active in patients with newly diagnosed multiple myeloma," the lead author says. "Our results support the development of a phase 3 trial studying this combination for multiple myeloma."&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/7xoF8ecMQjw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 17 Nov 2014 16:44:09 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/11/141117164409.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/11/141117164409.htm</feedburner:origLink></item>
		<item>
			<title>Updated criteria for diagnosing multiple myeloma published by international research group</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/7-SpzRoyVQU/141027100459.htm</link>
			<description>The International Myeloma Working Group today announced that it has updated the criteria for diagnosing multiple myeloma. Multiple myeloma is a blood cancer that forms in a type of white blood cell called a plasma cell.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/7-SpzRoyVQU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 27 Oct 2014 10:04:59 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/10/141027100459.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/10/141027100459.htm</feedburner:origLink></item>
		<item>
			<title>New cancer drug to begin trials in multiple myeloma patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/uA-OAESlQq0/141013123034.htm</link>
			<description>A new cancer drug has been developed, which researchers plan to trial in multiple myeloma patients by the end of next year. The researchers report how the drug, known as DTP3, kills myeloma cells in laboratory tests in human cells and mice, without causing any toxic side effects, which is the main problem with most other cancer drugs. The new drug works by stopping a key process that allows cancer cells to multiply.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/uA-OAESlQq0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 13 Oct 2014 12:30:34 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/10/141013123034.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/10/141013123034.htm</feedburner:origLink></item>
		<item>
			<title>Novel compound prevents metastasis of multiple myeloma in mouse studies</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/kp4M2gratXk/140925132309.htm</link>
			<description>The compound olaptesed pegol can stop multiple myeloma from spreading in mouse models, researchers have found, potentially leading to a new approach in addressing the challenge of metastasis, one of the deadliest aspects of cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/kp4M2gratXk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Sep 2014 13:23:09 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/09/140925132309.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/09/140925132309.htm</feedburner:origLink></item>
		<item>
			<title>Understanding, improving body's fight against pathogens</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/PqTyLeWOJPk/140902115036.htm</link>
			<description>The crucial role of two signalling molecules, DOK3 and SHP1, in the development and production of plasma cells has been uncovered by researchers. These discoveries advance the understanding of plasma cells and the antibody response, and may lead to optimization of vaccine development and improved treatment for patients with autoimmune diseases such as lupus and tumors such as multiple myeloma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/PqTyLeWOJPk" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2014/09/140902115036.jpg" height="221" width="300" />
			<pubDate>Tue, 02 Sep 2014 11:50:36 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/09/140902115036.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/09/140902115036.htm</feedburner:origLink></item>
		<item>
			<title>Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/HFp1AZxEyeA/140827112135.htm</link>
			<description>While many scientists are trying to prevent the onset of a cancer defense mechanism known as autophagy, other researchers are leveraging it in a new therapy that causes the process to culminate in cell death rather than survival.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/HFp1AZxEyeA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 27 Aug 2014 11:21:35 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/08/140827112135.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/08/140827112135.htm</feedburner:origLink></item>
		<item>
			<title>Calcium isotope analysis used to predict myeloma progression</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/QXPXJgd4p0Y/140812122415.htm</link>
			<description>A staple of Earth science research can be used in biomedical settings to predict the course of disease, researchers have demonstrated. The researchers tested a new approach to detecting bone loss in cancer patients by using calcium isotope analysis to predict whether myeloma patients are at risk for developing bone lesions, a hallmark of the disease.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/QXPXJgd4p0Y" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 12 Aug 2014 12:24:15 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/08/140812122415.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/08/140812122415.htm</feedburner:origLink></item>
		<item>
			<title>Drug may aid multiple myeloma patients who suffer from low platelet counts</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/cncr_OztC0c/140728094300.htm</link>
			<description>A previously unknown but crucial component in the process to make platelets has been identified by researchers, a discovery that could help spare multiple myeloma patients from a dangerous side effect of the primary drug (bortezomib) used to treat their cancer. Multiple myeloma is a blood cancer that develops in bone marrow and affects plasma cells, which produce antibodies to help protect against infection.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/cncr_OztC0c" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 28 Jul 2014 09:43:00 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/07/140728094300.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/07/140728094300.htm</feedburner:origLink></item>
		<item>
			<title>Scientists engineer nanoparticles to prevent bone cancer, strengthen bones</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/xH4I4FB9HDw/140630164150.htm</link>
			<description>Nanomedicine technologies have been utilized to develop a drug-delivery system that can precisely target and attack cancer cells in the bone, as well as increase bone strength and volume to prevent bone cancer progression. "We engineered and tested a bone-targeted nanoparticle system to selectively target the bone microenvironment and release a therapeutic drug in a spatiotemporally controlled manner, leading to bone microenvironment remodeling and prevention of disease progression," a co-lead study author said.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/xH4I4FB9HDw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 30 Jun 2014 16:41:50 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/06/140630164150.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/06/140630164150.htm</feedburner:origLink></item>
		<item>
			<title>Immune therapy might be effective for multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/_UhfvXf9yIc/140512124312.htm</link>
			<description>Genetically modified immune cells might effectively treat multiple myeloma, a disease that remains incurable and will account for an estimated 24,000 new cases and 11,100 deaths in 2014, new research finds. The researchers modified T lymphocytes to target a molecule called CS1, which is found on myeloma cells, and to kill the cells. The findings support testing the potential therapy in a clinical trial.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/_UhfvXf9yIc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 12 May 2014 12:43:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/05/140512124312.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/05/140512124312.htm</feedburner:origLink></item>
		<item>
			<title>New myeloma-obesity research shows drugs can team with body's defenses</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/iJHw5vxchew/140502102510.htm</link>
			<description>Obesity increases the risk of myeloma, and with obesity rates climbing particularly in the Hispanic population, one researcher is tracing the ways it affects cancer and use those pathways for more effective treatments. "I'm predicting an increase in multiple myeloma," said the researcher, "and with the obesity problems we see in the Hispanic population, there could be a serious health disparity on the horizon."&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/iJHw5vxchew" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 02 May 2014 10:25:10 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/05/140502102510.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/05/140502102510.htm</feedburner:origLink></item>
		<item>
			<title>New combination therapy developed for multiple myeloma</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/J0ArfgyIcJc/140501112325.htm</link>
			<description>Each year, more than 25,000 Americans are diagnosed with multiple myeloma, a form of blood cancer that often develops resistance to therapies. However, researchers are reporting promising results from laboratory experiments testing a new combination therapy that could potentially overcome the resistance hurdle.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/J0ArfgyIcJc" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2014/05/140501112325.jpg" height="451" width="300" />
			<pubDate>Thu, 01 May 2014 11:23:25 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/05/140501112325.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/05/140501112325.htm</feedburner:origLink></item>
		<item>
			<title>Pathways that direct immune system to turn 'on' or 'off' found</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/C-h2IBXlwdo/140317124952.htm</link>
			<description>Manipulating the CD80/CD86 pathway may yield new strategies for treating multiple myeloma, new research on dendritic cells suggests. This research focused on the immune systemâs dendritic cells (DCs), crucial cells that initiate and regulate immune responses. For example, the dendritic cells activate T lymphocytes to fight an infection or cancer. Curiously, they are also known to suppress the immune response. Determining when DCs turn the immune response âonâ or âoffâ is a major question in immunology.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/C-h2IBXlwdo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 17 Mar 2014 12:49:52 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/03/140317124952.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/03/140317124952.htm</feedburner:origLink></item>
		<item>
			<title>Precursor of multiple myeloma more common in blacks than whites</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/1zlQDGFk-JU/140224123751.htm</link>
			<description>Blacks may be twice as likely as whites to develop multiple myeloma because they are more likely to have a precursor condition known as monoclonal gammopathy of undetermined significance (MGUS), a study has found. Not only is MGUS more common in blacks, but the type seen in the black population is also more apt to have features associated with a higher risk of progression to full-blown multiple myeloma, a cancer of a type of white blood cell in bone marrow.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/1zlQDGFk-JU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 24 Feb 2014 12:37:51 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/02/140224123751.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/02/140224123751.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma, myeloid leukemia therapies could be enhanced by experimental drug</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/he9jcdiG78g/140218114309.htm</link>
			<description>An experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies, a pre-clinical study suggests. The study showed that dinaciclib disrupted a cell survival mechanism known as the unfolded protein response (UPR). Without the UPR, multiple myeloma and myeloid leukemia cells were unable to combat damage caused by some anti-cancer agents. Dinaciclib is a member of a class of drugs known as cyclin-dependent kinase (CDK) inhibitors. CDKs regulate a series of events known as the cell cycle, or cell-division cycle, that lead to the division and duplication of cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/he9jcdiG78g" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 18 Feb 2014 11:43:09 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/02/140218114309.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/02/140218114309.htm</feedburner:origLink></item>
		<item>
			<title>High-tech 'whole body' scan could improve treatment of bone marrow cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/rA8b5nnEDH8/140128153944.htm</link>
			<description>A pioneering scanning technique that can image a patient's entire body can reveal where cancer is affecting the bones and guide doctors in their choice of treatment, new research reveals.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/rA8b5nnEDH8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 28 Jan 2014 15:39:44 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/01/140128153944.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/01/140128153944.htm</feedburner:origLink></item>
		<item>
			<title>Multiple myeloma study uncovers genetic diversity within tumors</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/cCAvfWfW0vk/140113125144.htm</link>
			<description>The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought. Through results published, a team of researchers has shown that an individual patient's tumor can harbor populations of cancer cells equipped with different mutations. These findings could have therapeutic implications for patients in the future.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/cCAvfWfW0vk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 13 Jan 2014 12:51:44 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2014/01/140113125144.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2014/01/140113125144.htm</feedburner:origLink></item>
		<item>
			<title>Promising results for Swedish cancer drug candidate</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/S0sj2GcVJ4c/131206101609.htm</link>
			<description>A new study presents very promising results for the treatment of the cancer form multiple myeloma. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/S0sj2GcVJ4c" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 06 Dec 2013 10:16:09 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/12/131206101609.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/12/131206101609.htm</feedburner:origLink></item>
		<item>
			<title>Cancer researchers discover root cause of multiple myeloma relapse</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/LXrXyyq-cPc/130909131130.htm</link>
			<description>Clinical researchers have discovered why multiple myeloma, an incurable cancer of the bone marrow, persistently escapes cure by an initially effective treatment that can keep the disease at bay for up to several years.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/LXrXyyq-cPc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 09 Sep 2013 13:11:30 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/09/130909131130.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/09/130909131130.htm</feedburner:origLink></item>
		<item>
			<title>Ingredient in turmeric spice when combined with anti-nausea drug kills cancer cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/HDkanjU6MWo/130820114154.htm</link>
			<description>In a laboratory, preclinical study researchers combined structural features from anti-nausea drug thalidomide with common kitchen spice turmeric to create hybrid molecules that effectively kill multiple myeloma cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/HDkanjU6MWo" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 20 Aug 2013 11:41:54 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/08/130820114154.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/08/130820114154.htm</feedburner:origLink></item>
		<item>
			<title>Major study links aging gene to blood cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/i1ig302bFEM/130818144426.htm</link>
			<description>A gene that helps control the ageing process by acting as a cell's internal clock has been linked to cancer by a major new study. Scientists found a genetic variant that influences the ageing process among four new variants they linked to myeloma -- one of the most common types of blood cancer. The study more than doubles the number of genetic variants linked to myeloma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/i1ig302bFEM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 18 Aug 2013 14:44:26 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/08/130818144426.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/08/130818144426.htm</feedburner:origLink></item>
		<item>
			<title>Aggressive breast cancers may be sensitive to drugs clogging their waste disposal</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/fBI1WuHuCCw/130812154414.htm</link>
			<description>A new report suggests that "triple-negative" breast cancers may be vulnerable to drugs that attack the proteasome. This cellular structure acts as the cell's waste disposal, breaking down damaged or unneeded proteins.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/fBI1WuHuCCw" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 12 Aug 2013 15:44:14 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/08/130812154414.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/08/130812154414.htm</feedburner:origLink></item>
		<item>
			<title>Research IDs potential treatment for deadly, HIV-related blood cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/4LjT4kKLU5o/130625150942.htm</link>
			<description>Researchers have discovered a promising new way to treat a rare and aggressive blood cancer most commonly found in people infected with HIV.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/4LjT4kKLU5o" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 25 Jun 2013 15:09:42 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/06/130625150942.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/06/130625150942.htm</feedburner:origLink></item>
		<item>
			<title>Possible treatment for serious blood cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/BR-qXlhrdPg/130506095301.htm</link>
			<description>A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. New tests have shown that the antibody is able to destroy myeloma cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/BR-qXlhrdPg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 06 May 2013 09:53:01 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/05/130506095301.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/05/130506095301.htm</feedburner:origLink></item>
		<item>
			<title>Scientists discover new way protein degradation is regulated</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/multiple_myeloma/~3/gBkeDfFRvwk/130426114644.htm</link>
			<description>Researchers have identified the mechanism by which the cellâs proteasome ramps up its activity to take care of unwanted and potentially toxic proteins. The finding has implications for treating muscle wasting and neurodegeneration, and suggests that small molecule inhibitors of this mechanism may be clinically useful in treating multiple myeloma.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/multiple_myeloma/~4/gBkeDfFRvwk" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2013/04/130426114644.jpg" height="279" width="300" />
			<pubDate>Fri, 26 Apr 2013 11:46:44 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2013/04/130426114644.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2013/04/130426114644.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 22:37:01 EST -->
